Should You Buy Quest Diagnostics Ahead of Earnings?

Core Viewpoint - Quest Diagnostics Incorporated (DGX) is positioned favorably for an upcoming earnings report, with positive trends indicating a potential earnings beat [1][5]. Earnings Estimate Revisions - Recent favorable earnings estimate revisions for Quest Diagnostics suggest a positive outlook, as analysts have raised their estimates just before the earnings report [2][5]. - The Most Accurate Estimate for the current quarter stands at $2.59 per share, slightly above the Zacks Consensus Estimate of $2.57 per share, indicating recent upward revisions by analysts [3]. Earnings ESP and Historical Performance - Quest Diagnostics has a Zacks Earnings ESP of +0.67%, which is a positive indicator heading into earnings season [3]. - Historical data shows that stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of delivering positive surprises and have averaged over 28% in annual returns [4]. Investment Consideration - Given the positive earnings estimate revisions and the current Zacks Rank of 3, investors may want to consider Quest Diagnostics as a potential investment ahead of the earnings report [5].